Company Update – Merck & Co. Inc. (NYSE:MRK) – Merck Sues Actavis Over Generic NuvaRing

[at Wall St. Cheat Sheet] – Merck has filed a lawsuit against Actavis on claims that Actavis has been marketing a generic version of NuvaRing before Merck’s patent is set to expire. Read . . . → Read More: Company Update – Merck & Co. Inc. (NYSE:MRK) – Merck Sues Actavis Over Generic NuvaRing Similar posts: Company Update: Merck & Co. Inc. (NYSE:MRK) – Merck Sues Actavis Unit Over Patent for Generic NuvaRing Company Update: Johnson & Johnson (NYSE:JNJ) – EU regulators fine J&J, Novartis for generic drug deal Boeing’s Double Top: Will the company continue to soar?